The study will evaluate the safety and efficacy of a new shot designed to target the omicron coronavirus variant, which can evade some of the protection from existing vaccines.
“Vaccines are not magic forcefields,” Johns Hopkins’ Dr. Amesh Adalja told Forbes. “You are getting vaccinated to prevent yourself from getting severe illness from Covid-19,” not to stop getting infected at all.
New research suggests the subvariant, which rapidly became the dominant strain in Denmark, is 33% more likely to infect others compared to the original omicron variant.